FACULTAD DE CIENCIAS BIOMÉDICAS Y DE LA SALUD
Facultad
Charité
Berlín, AlemaniaPublicaciones en colaboración con investigadores/as de Charité (30)
2024
-
Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522
Annals of Oncology
-
Radiographic Progression in Sacroiliac Joints in Patients With Axial Spondyloarthritis: Results From a Five-Year International Observational Study
ACR Open Rheumatology, Vol. 6, Núm. 2, pp. 103-110
2023
-
Prognostic and predictive impact of gene expression in node-positive early breast cancer patients receiving dose-dense versus standard-dose adjuvant chemotherapy
Molecular Oncology, Vol. 17, Núm. 6, pp. 1060-1075
2022
-
Characteristics of patients with axial spondyloarthritis by geographic regions: PROOF multicountry observational study baseline results
Rheumatology (United Kingdom), Vol. 61, Núm. 8, pp. 3299-3308
-
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer
New England Journal of Medicine, Vol. 386, Núm. 6, pp. 556-567
-
Gene signatures in patients with early breast cancer and relapse despite pathologic complete response
npj Breast Cancer, Vol. 8, Núm. 1
-
Multiple Bayesian network meta-analyses to establish therapeutic algorithms for metastatic triple negative breast cancer
Cancer Treatment Reviews, Vol. 111
2021
-
A novel circulating microRNA for the detection of acute myocarditis
New England Journal of Medicine, Vol. 384, Núm. 21, pp. 2014-2027
-
Anthracyclines strike back: Rediscovering non‐pegylated liposomal doxorubicin in current therapeutic scenarios of breast cancer
Cancers, Vol. 13, Núm. 17
-
Real-world outcomes using a spinal cord stimulation device capable of combination therapy for chronic pain: A european, multicenter experience
Journal of Clinical Medicine, Vol. 10, Núm. 18
-
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
npj Breast Cancer, Vol. 7, Núm. 1
2020
-
Effects of the chymase inhibitor fulacimstat on adverse cardiac remodeling after acute myocardial infarction—Results of the Chymase Inhibitor in Adverse Remodeling after Myocardial Infarction (CHIARA MIA) 2 trial
American Heart Journal, Vol. 224, pp. 129-137
-
Efficacy and Safety of Trastuzumab Emtansine plus Capecitabine vs Trastuzumab Emtansine Alone in Patients with Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer: A Phase 1 and Randomized Phase 2 Trial
JAMA Oncology, Vol. 6, Núm. 8, pp. 1203-1209
-
New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab
Frontiers in Neurology, Vol. 11
2019
-
A Medication Adherence App for Children With Sickle Cell Disease: Qualitative Study
JMIR mHealth and uHealth, Vol. 7, Núm. 6, pp. e8130
-
A medication adherence app for children with sickle cell disease: Qualitative study
JMIR mHealth and uHealth, Vol. 7, Núm. 6
-
Exercise training for patients with type 2 diabetes and cardiovascular disease: What to pursue and how to do it. A Position Paper of the European Association of Preventive Cardiology (EAPC)
European Journal of Preventive Cardiology, Vol. 26, Núm. 7, pp. 709-727
-
Exercise training to reduce cardiovascular risk in patients with metabolic syndrome and type 2 diabetes mellitus: How does it work?
European Journal of Preventive Cardiology, Vol. 26, Núm. 7, pp. 701-708
2018
-
A multicentre randomized pilot trial on the effectiveness of different levels of cooling in comatose survivors of out-of-hospital cardiac arrest: the FROST-I trial
Intensive Care Medicine, Vol. 44, Núm. 11, pp. 1807-1815
2017
-
Brain tumors in eloquent areas: A European multicenter survey of intraoperative mapping techniques, intraoperative seizures occurrence, and antiepileptic drug prophylaxis
Neurosurgical Review, Vol. 40, Núm. 2, pp. 287-298